REGENXBIO Inc.

In News

Diabetic Retinopathy Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Techn, Avirmax - Barchart.com

Barchart.com - Jun 12, 2026

Before Buying Regenxbio Inc (RGNX) Stock, Check Out the Cash Runway - Yahoo Finance

Yahoo Finance - May 20, 2026

REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting - PR Newswire

PR Newswire - May 07, 2026

H.C. Wainwright lowers Regenxbio stock price target on trial data - Investing.com

Investing.com - Jun 08, 2026

JPMorgan Chase & Co. Reduces Stake in Regenxbio Inc. - GuruFocus

GuruFocus - Jun 06, 2026

[Form 4] REGENXBIO Inc. Insider Trading Activity - Stock Titan

Stock Titan - Jun 02, 2026

Regenxbio's MPS II Gene Therapy RGX-121 Hit With CRL - NeurologyLive

NeurologyLive - Feb 09, 2026

FDA Slams REGENXBIO's MPS II Gene Therapy RGX-121 With CRL - CGTLive®

CGTLive® - Feb 09, 2026

Stifel reiterates Buy rating on Regenxbio stock ahead of trial data - Investing.com

Investing.com - May 27, 2026

REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program - PR Newswire

PR Newswire - Jan 11, 2026

REGENXBIO (RGNX) offers exchange of 2.9M eligible options for replacements - Stock Titan

Stock Titan - Jun 03, 2026

REGENXBIO to Participate in Upcoming Investor Conferences - Yahoo Finance

Yahoo Finance - May 18, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment